chr2-130182451-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000409031.5(SMPD4):c.-850T>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000356 in 1,403,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000409031.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000356 AC: 5AN: 1403900Hom.: 0 Cov.: 35 AF XY: 0.00000144 AC XY: 1AN XY: 693310
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.169A>C (p.K57Q) alteration is located in exon 1 (coding exon 1) of the MZT2B gene. This alteration results from a A to C substitution at nucleotide position 169, causing the lysine (K) at amino acid position 57 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.